Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

80.47
Delayed Data
As of Jun 24
 -2.90 / -3.48%
Today’s Change
80.22
Today|||52-Week Range
123.37
-20.48%
Year-to-Date
The 5 Best Healthcare ETFs
7:22am / MotleyFool.com - Paid Partner Content
3 Stocks Pulling The Drugs Industry Downward
Jun 21 / TheStreet.com - Paid Partner Content
3 Biotech Stocks to Buy Now for the Long Haul
Jun 25 / MotleyFool.com - Paid Partner Content
Gilead Presents Favorable Preliminary Bictegravir HIV Data
Jun 21 / Zacks.com - Paid Partner Content
Can Gilead Sciences Rebound in the Second Half of 2016?
Jun 25 / MotleyFool.com - Paid Partner Content
New Strong Sell Stocks for June 21st
Jun 21 / Zacks.com - Paid Partner Content
RBC sees biopharma 'insulated' from Brexit, says buy Celgene for bounceback
Jun 24 / TheStreet.com - Paid Partner Content
These 5 Biotech Stocks Are Ridiculously Cheap
Jun 21 / MotleyFool.com - Paid Partner Content
Gilead's (GILD) HIV Treatment Odefsey Gains Approval in EU
Jun 24 / Zacks.com - Paid Partner Content
Why Achillion Pharmaceuticals Is Down Big in 2016
Jun 20 / MotleyFool.com - Paid Partner Content
Gilead (GILD) Weak In Early Morning Trading
Jun 24 / TheStreet.com - Paid Partner Content
3 Finds in Biotech's 'Pocket of Value'
Jun 20 / TheStreet.com - Paid Partner Content
Corporate Share Buybacks Rise to Record Level in First Quarter
Jun 23 / GuruFocus News - Paid Partner Content
Gilead Sciences: Where's the Value?
Jun 19 / MotleyFool.com - Paid Partner Content
Uh-oh. Is the stock market a bubble again?
Jun 23 / CNNMoney.com
The 3 Best Dividend Stocks for Beginning Investors
Jun 19 / MotleyFool.com - Paid Partner Content
The 3 Most Important Data Releases and FDA Decisions in the Second Half of 2016
Jun 23 / MotleyFool.com - Paid Partner Content
2 Biotech Stocks That Could Raise Their Dividends -- and 1 That Won't
Jun 18 / MotleyFool.com - Paid Partner Content
Share Buybacks Rise to Record Level in First Quarter
Jun 22 / GuruFocus News - Paid Partner Content
3 Reasons Gilead Sciences Is a Buy
Jun 17 / MotleyFool.com - Paid Partner Content
Gilead Downside Is Path of Least Resistance
Jun 22 / TheStreet.com - Paid Partner Content
New Strong Sell Stocks for June 17th
Jun 17 / Zacks.com - Paid Partner Content
Biotech Stocks Rally on Medicare Cost-Cutting Stand Down
Jun 22 / TheStreet.com - Paid Partner Content
3 Biotech Stocks to Buy If the Market Crashes
Jun 14 / MotleyFool.com - Paid Partner Content
Stock Market News for June 22, 2016
Jun 22 / Zacks.com - Paid Partner Content
India buyers club: The new way for Americans to buy cheap drugs
Jun 02 / CNNMoney.com
Can These Upstarts Knock Gilead Sciences Off Its Perch?
Jun 22 / MotleyFool.com - Paid Partner Content